Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PPARγ-IN-2
Cat. No.:
OB0425LY-198
Appearance:
Solid
Purity:
99.57%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
PPARγ-IN-2 is a selective PPARγ antagonist that blocks the activity of this nuclear receptor, thereby regulating adipocyte differentiation and glucose metabolism.
Synonyms:
PPARgamma-N-2; 2682078-97-1; PPARγ-IN 2
CAS No.:
2682078-97-1
Compound CID:
168510610
Formula:
C19H21N5O
Formula Weight:
335.4
Specification
Target:
PPAR
Pathway:
Cell cycle/DNA damage; Metabolic enzyme/Protease; Vitamin D related/Nuclear receptor
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
PPARγ-IN-2 is suitable for the study of biological processes associated with metabolic syndrome, diabetes and obesity, as well as for evaluating the potential of PPARγ-targeted therapies.
